Abstract

Mitochondrial dysfunction leads to osteoarthritis (OA) and disc degeneration. Hypoxia inducible factor-1α (HIF-1α) mediated mitophagy has a protective role in several diseases. However, the underlying mechanism of HIF-1α mediated mitophagy in OA remains largely unknown. This current study was performed to determine the effect of HIF-1α mediated mitophagy on OA. Therefore, X-ray and tissue staining including HE staining, safranin O-fast green (S-O) and Alcian Blue were used to assess imageology and histomorphology differences of mouse knee joint. Transcriptional analysis was used to find the possible targets in osteoarthritis. Western blot analysis, RT-qPCR and immunofluorescence staining were used to detect the changes in gene and protein levels in the vitro experiment. The expression of HIF-1α was increased in human and mouse OA cartilage. HIF-1α knockdown by siRNA further impair the hypoxia-induced mitochondrial dysfunction; In contrast, HIF-1α mediated protective role was reinforced by prolylhydroxylase (PHD) inhibitor dimethyloxalylglycine (DMOG). In addition, HIF-1α stabilization could alleviate apoptosis and senescence via mitophagy in chondrocytes under hypoxia condition, which could also ameliorate surgery-induced cartilage degradation in mice OA model. In conclusion, HIF-1α mediated mitophagy could alleviate OA, which may serve as a promising strategy for OA treatment.

Details

Title
Stabilization of HIF-1α alleviates osteoarthritis via enhancing mitophagy
Author
Hu Sunli 1 ; Zhang Chunwu 2 ; Ni Libin 3 ; Huang Chongan 3 ; Chen, Dingwen 4 ; Shi Keqing 2 ; Jin, Haiming 5 ; Zhang Kairui 1 ; Yao, Li 1 ; Xie, Ling 6 ; Fang Mingqiao 1 ; Guangheng, Xiang 1 ; Wang, Xiangyang 5 ; Xiao, Jian 7   VIAFID ORCID Logo 

 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632); Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990); Wenzhou Medical University, The Second School of Medicine, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990) 
 The first Affiliated Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.414906.e) (ISNI:0000 0004 1808 0918) 
 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632); Wenzhou Medical University, The Second School of Medicine, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990) 
 Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990); Wenzhou Medical University, The Second School of Medicine, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990) 
 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632) 
 Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990) 
 The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Department of Orthopaedics, Wenzhou, China (GRID:grid.417384.d) (ISNI:0000 0004 1764 2632); Wenzhou Medical University, Molecular Pharmacology Research Center, School of Pharmaceutical Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990) 
Publication year
2020
Publication date
Jun 2020
Publisher
Springer Nature B.V.
e-ISSN
20414889
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2417167613
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.